Metabolic disruption in male mice due to fetal exposure to low but not high doses of bisphenol A (BPA): Evidence for effects on body weight, food intake, adipocytes, leptin, adiponectin, insulin and glucose regulation

Reproductive Toxicology

Volumn 42, Issue , 2013, Pages 256-268

  Angle, Brittany M ^a   Do, Rylee Phuong ^a   Ponzi, Davide ^a   Stahlhut, Richard W ^a   Drury, Bertram E ^a   Nagel, Susan C ^b   Welshons, Wade V ^a   Besch Williford, Cynthia L ^c   Palanza, Paola ^d   Parmigiani, Stefano ^d   vom Saal, Frederick S ^a   Taylor, Julia A ^a  

^a UNIVERSITY OF MISSOURI   (United States)

^b University of Missouri   (United States)

^c IDEXX RADIL   (United States)

^d UNIVERSITY OF PARMA   (Italy)

Author keywords

Adipocytes; Endocrine disruption; Food intake; Glucose tolerance; Metabolic syndrome

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; ADIPONECTIN; INSULIN; LEPTIN;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; FOOD INTAKE; GLUCOSE TOLERANCE; HORMONE BLOOD LEVEL; INSULIN BLOOD LEVEL; LIVER WEIGHT; MALE; METABOLIC DISORDER; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PRENATAL EXPOSURE; PROTEIN BLOOD LEVEL;

ANIMALIA; MUS;

ADIPOCYTES; ENDOCRINE DISRUPTION; FOOD INTAKE; GLUCOSE TOLERANCE; METABOLIC SYNDROME;

ABDOMINAL FAT; ADIPOCYTES; ADIPONECTIN; ANIMALS; BENZHYDRYL COMPOUNDS; BODY WEIGHT; CELL COUNT; CELL SIZE; EATING; ENDOCRINE DISRUPTORS; FEMALE; GLUCOSE; GLUCOSE TOLERANCE TEST; INSULIN; LEPTIN; MALE; MATERNAL-FETAL EXCHANGE; MICE; PHENOLS; PREGNANCY;

EID: 84887825705     PISSN: 08906238     EISSN: 18731708     Source Type: Journal    
DOI: 10.1016/j.reprotox.2013.07.017     Document Type: Article

References (96)

1. Shuster A., Patlas M., Pinthus J.H., Mourtzakis M. The clinical importance of visceral adiposity: a critical review of methods for visceral adipose tissue analysis. British Journal of Radiology 2012, 85:1-10.
2. Alonso-Magdalena P., Quesada I., Nadal A. Endocrine disruptors in the etiology of type 2 diabetes mellitus. Nature Reviews Endocrinology 2011, 7:346-353.
3. Kasturi S.S., Tannir J., Brannigan R.E. The metabolic syndrome and male infertility. Journal of Andrology 2008, 29:251-259.
4. Heindel J.J., vom Saal F.S. Overview of obesity and the role of developmental nutrition and environmental chemical exposures. Molecular and Cellular Endocrinology 2009, 304:90-96.
5. Janesick A., Blumberg B. Obesogens, stem cells and the developmental programming of obesity. International Journal of Andrology 2012, 35:437-448.
6. vom Saal F.S., Nagel S.C., Coe B.L., Angle B.M., Taylor J.A. The estrogenic endocrine disrupting chemical bisphenol A (BPA) and obesity. Molecular and Cellular Endocrinology 2012, 354:74-84.
7. Cabaton N.J., Canlet C., Wadia P.R., Tremblay-Franco M., Gautier R., Molina J., et al. Effects of low doses of bisphenol A on the metabolome of perinatally exposed CD-1 mice. Environmental Health Perspectives 2013, 121:586-593.
8. Cao J., Rebuli M.E., Rogers J., Todd K.L., Leyrer S.M., Ferguson S.A., et al. Prenatal bisphenol A (BPA) exposure alters sex specific estrogen receptor expression in the neonatal rat hypothalamus and amygdala. Toxicological Sciences 2013, [Epub ahead of print].
9. Wei J., Lin Y., Li Y., Ying C., Chen J., Song L., et al. Perinatal exposure to bisphenol A at reference dose predisposes offspring to metabolic syndrome in adult rats on a high-fat diet. Endocrinology 2011, 152:3049-3061.
10. Patisaul H.B., Sullivan A.W., Radford M.E., Walker D.M., Adewale H.B., Winnik B., et al. Anxiogenic effects of developmental bisphenol A exposure are associated with gene expression changes in the juvenile rat amygdala and mitigated by soy. PLoS ONE 2012, 7:e43890.
11. Alonso-Magdalena P., Vieira E., Soriano S., Menes L., Burks D., Quesada I., et al. Bisphenol A exposure during pregnancy disrupts glucose homeostasis in mothers and adult male offspring. Environmental Health Perspectives 2010, 118:1243-1250.
12. Newbold R.R., Padilla-Banks E., Snyder R.J., Jefferson W.N. Developmental exposure to estrogenic compounds and obesity. Birth Defects Research A: Clinical and Molecular Teratology 2005, 73:478-480.
13. Hugo E.R., Brandebourg T.D., Woo J.G., Loftus J., Alexander J.W., Ben-Jonathan N. Bisphenol A at environmentally relevant doses inhibits adiponectin release from human adipose tissue explants and adipocytes. Environmental Health Perspectives 2008, 116:1642-1647.
14. Marroqui L., Gonzalez A., Neco P., Caballero-Garrido E., Vieira E., Ripoll C., et al. Role of leptin in the pancreatic beta-cell: effects and signaling pathways. Journal of Molecular Endocrinology 2012, 49:R9-R17.
15. Somm E., Schwitzgebel V.M., Vauthay D.M., Camm E.J., Chen C.Y., Giacobino J.P., et al. Prenatal nicotine exposure alters early pancreatic islet and adipose tissue development with consequences on the control of body weight and glucose metabolism later in life. Endocrinology 2008, 149:6289-6299.
16. Somm E., Schwitzgebel V.M., Toulotte A., Cederroth C.R., Combescure C., Nef S., et al. Perinatal exposure to bisphenol A alters early adipogenesis in the rat. Environmental Health Perspectives 2009, 117:1549-1555.
17. Cooke P.S., Naaz A. Role of estrogens in adipocyte development and function. Experimental Biology and Medicine (Maywood, NJ) 2004, 229:1127-1135.
18. Lang I.A., Galloway T.S., Scarlett A., Henley W.E., Depledge M., Wallace R.B., et al. Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults: evidence from NHANES 2003/4. JAMA 2008, 300:1303-1310.
19. Melzer D., Rice N.E., Lewis C., Henley W.E., Galloway T.S. Association of urinary bisphenol A concentration with heart disease: evidence from NHANES 2003/06. PLoS ONE 2010, 5:e8673.
20. Melzer D., Osborne N.J., Henley W.E., Cipelli R., Young A., Money C., et al. Urinary bisphenol A concentration and risk of future coronary artery disease in apparently healthy men and women. Circulation 2012, 125:1482-1490.
21. Trasande L., Attina T.M., Blustein J. Association between urinary bisphenol A concentration and obesity prevalence in children and adolescents. JAMA 2012, 308:1113-1121.
22. Richter C.A., Birnbaum L.S., Farabollini F., Newbold R.R., Rubin B.S., Talsness C.E., et al. In vivo effects of bisphenol A in laboratory rodent studies. Reproductive Toxicology 2007, 24:199-224.
23. Rubin B.S., Bisphenol A. An endocrine disruptor with widespread exposure and multiple effects. Journal of Steroid Biochemistry and Molecular Biology 2011, 127:27-34.
24. Vandenberg L.N., Colborn T., Hayes T.B., Heindel J.J., Jacobs D.R., Lee D.-H., et al. Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocrine Reviews 2012, 33:378-455.
25. Bailin P.D., Byrne M., Lewis S., Liroff R. Public awareness drives market for safer alternatives: bisphenol A market analysis report 2008, http://www.iehn.org/publications.reports.bpa.php (accessed 20.04.11].
26. Calafat A.M., Ye X., Wong L.Y., Reidy J.A., Needham L.L. Exposure of the U.S. population to bisphenol A and 4-tertiary-octylphenol: 2003-2004. Environmental Health Perspectives 2008, 116:39-44.
27. Stahlhut R.W., Welshons W.V., Bisphenol Swan S.H. A data in NHANES suggest longer than expected half-life, substantial nonfood exposure, or both. Environmental Health Perspectives 2009, 117:784-789.
28. Vandenberg L.N., Chahoud I., Heindel J.J., Padmanabhan V., Paumgartten F.J., Schoenfelder G. Urinary, circulating, and tissue biomonitoring studies indicate widespread exposure to bisphenol A. Environmental Health Perspectives 2010, 118:1055-1070.
29. Schonfelder G., Wittfoht W., Hopp H., Talsness C.E., Paul M., Chahoud I. Parent bisphenol A accumulation in human maternal-fetal-placental unit. Environmental Health Perspectives 2002, 110:A703-A707.
30. Prins G.S., Ye S.H., Birch L., Ho S.M., Kannan K. Serum bisphenol A pharmacokinetics and prostate neoplastic responses following oral and subcutaneous exposures in neonatal Sprague-Dawley rats. Reproductive Toxicology 2011, 31:1-9.
31. Taylor J.A., Welshons W.V., Vom Saal F.S. No effect of route of exposure (oral; subcutaneous injection) on plasma bisphenol A throughout 24h after administration in neonatal female mice. Reproductive Toxicology 2008, 25:169-176.
32. Taylor J.A., Vom Saal F.S., Welshons W.V., Drury B., Rottinghaus G., Hunt P.A., et al. Similarity of bisphenol A pharmacokinetics in rhesus monkeys and mice: relevance for human exposure. Environmental Health Perspectives 2011, 119:422-430.
33. Welshons W.V., Nagel S.C., vom Saal F.S. Large effects from small exposures. III. Endocrine mechanisms mediating effects of bisphenol A at levels of human exposure. Endocrinology 2006, 147:S56-S69.
34. Aghajanova L., Giudice L.C. Effect of bisphenol A on human endometrial stromal fibroblasts in vitro. Reproductive Biomedicine Online 2011, 22:249-256.
35. Howdeshell K.L., Hotchkiss A.K., Thayer K.A., Vandenbergh J.G., vom Saal F.S. Exposure to bisphenol A advances puberty. Nature 1999, 401:763-764.
36. Takai Y., Tsutsumi O., Ikezuki Y., Hiroi H., Osuga Y., Momoeda M., et al. Estrogen receptor-mediated effects of a xenoestrogen, bisphenol A, on preimplantation mouse embryos. Biochemical and Biophysical Research Communications 2000, 270:918-921.
37. Rubin B.S., Murray M.K., Damassa D.A., King J.C., Soto A.M. Perinatal exposure to low doses of bisphenol A affects body weight, patterns of estrous cyclicity, and plasma LH levels. Environmental Health Perspectives 2001, 109:675-680.
38. Akingbemi B.T., Sottas C.M., Koulova A.I., Klinefelter G.R., Hardy M.P. Inhibition of testicular steroidogenesis by the xenoestrogen bisphenol A is associated with reduced pituitary luteinizing hormone secretion and decreased steroidogenic enzyme gene expression in rat Leydig cells. Endocrinology 2004, 145:592-603.
39. Adewale H.B., Todd K.L., Mickens J.A., Patisaul H.B. The impact of neonatal bisphenol - a exposure on sexually dimorphic hypothalamic nuclei in the female rat. Neurotoxicology 2010, 32:38-49.
40. Nikaido Y., Yoshizawa K., Danbara N., Tsujita-Kyutoku M., Yuri T., Uehara N., et al. Effects of maternal xenoestrogen exposure on development of the reproductive tract and mammary gland in female CD-1 mouse offspring. Reproductive Toxicology 2004, 18:803-811.
41. Heindel J.J., vom Saal F.S. Meeting report: batch-to-batch variability in estrogenic activity in commercial animal diets - importance and approaches for laboratory animal research. Environmental Health Perspectives 2008, 116:389-393.
42. Cederroth C.R., Vinciguerra M., Kühne F., Madani R., Klein M., James R.W., et al. A phytoestrogen-rich diet increases energy expenditure and decreases adiposity in mice. Environmental Health Perspectives 2007, 115:1467-1473.
43. Ruhlen R.L., Howdeshell K.L., Mao J., Taylor J.A., Bronson F.H., Newbold R.R., et al. Low phytoestrogen levels in feed increase fetal serum estradiol resulting in the "fetal estrogenization syndrome" and obesity in CD-1 mice. Environmental Health Perspectives 2008, 116:322-328.
44. Patisaul H.B., Polston E.K. Influence of endocrine active compounds on the developing rodent brain. Brain Research Reviews 2008, 57:352-362.
45. Gill H.K., Wu G.Y. Non-alcoholic fatty liver disease and the metabolic syndrome: effects of weight loss and a review of popular diets. Are low carbohydrate diets the answer?. World Journal of Gastroenterology 2006, 12:345-353.
46. Thomas G., Sehgal A.R., Kashyap S.R., Srinivas T.R., Kirwan J.P., Navaneethan S.D. Metabolic syndrome and kidney disease: a systematic review and meta-analysis. Clinical Journal of the American Society of Nephrology 2011, 6:2364-2373.
47. Birnbaum L.S., Bucher J.R., Collman G.W., Zeldin D.C., Johnson A.F., Schug T.T., et al. Consortium-based science: the NIEHS's multipronged, collaborative approach to assessing the health effects of bisphenol A. Environmental Health Perspectives 2012, 120:1640-1644.
48. Markaverich B.M., Crowley J.R., Alejandro M.A., Shoulars K., Casajuna N., Mani S., et al. Leukotoxin diols from ground corncob bedding disrupt estrous cyclicity in rats and stimulate MCF-7 breast cancer cell proliferation. Environmental Health Perspectives 2005, 113:1698-1704.
49. Thigpen J.E., Setchell K.D., Kissling G.E., Locklear J., Caviness G.F., Whiteside T., et al. The estrogenic content of rodent diets, bedding, cages, and water bottles and its effect on bisphenol A studies. Journal of the American Association for Laboratory Animal Science 2013, 52:130-141.
50. Rosen E.D., MacDougald O.A. Adipocyte differentiation from the inside out. Nature Reviews Molecular Cell Biology 2006, 7:885-896.
51. vom Saal F.S., Quadagno D.M., Even M.D., Keisler L.W., Keisler D.H., Khan S. Paradoxical effects of maternal stress on fetal steroids and postnatal reproductive traits in female mice from different intrauterine positions. Biology of Reproduction 1990, 43:751-761.
52. Doerge D.R., Twaddle N.C., Vanlandingham M., Fisher J.W. Pharmacokinetics of bisphenol A in neonatal and adult Sprague-Dawley rats. Toxicology and Applied Pharmacology 2010, 247:158-165.
53. Do R.P., Stahlhut R.W., Ponzi D., Vom Saal F.S., Taylor J.A. Non-monotonic dose effects of in utero exposure to di(2-ethylhexyl) phthalate (DEHP) on testicular and serum testosterone and anogenital distance in male mouse fetuses. Reproductive Toxicology 2012, 34:614-621.
54. Kleiner D.E., Brunt E.M., Van Natta M., Behling C., Contos M.J., Cummings O.W., et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005, 41:1313-1321.
55. Misso M.L., Murata Y., Boon W.C., Jones M.E., Britt K.L., Simpson E.R. Cellular and molecular characterization of the adipose phenotype of the aromatase-deficient mouse. Endocrinology 2003, 144:1474-1480.
56. Li S., Shin H.J., Ding E.L., van Dam R.M. Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 2009, 302:179-188.
57. Zoeller R.T., Brown T.R., Doan L.L., Gore A.C., Skakkebaek N.E., Soto A.M., et al. Endocrine-disrupting chemicals and public health protection: a statement of principles from the Endocrine Society. Endocrinology 2012, 153:4097-4110.
58. Kochukov M.Y., Jeng Y.J., Watson C.S. Alkylphenol xenoestrogens with varying carbon chain lengths differentially and potently activate signaling and functional responses in GH3/B6/F10 somatomammotropes. Environmental Health Perspectives 2009, 117:723-730.
59. Zsarnovszky A., Le H.H., Wang H.S., Belcher S.M. Ontogeny of rapid estrogen-mediated extracellular signal-regulated kinase signaling in the rat cerebellar cortex: potent nongenomic agonist and endocrine disrupting activity of the xenoestrogen bisphenol A. Endocrinology 2005, 146:5388-5396.
60. Watson C.S., Jeng Y.J., Kochukov M.Y. Nongenomic signaling pathways of estrogen toxicity. Toxicological Sciences 2010, 115:1-11.
61. Routledge E.J., White R., Parker M.G., Sumpter J.P. Differential effects of xenoestrogens on coactivator recruitment by estrogen receptor (ER) alpha and ERbeta. Journal of Biological Chemistry 2000, 275:35986-35993.
62. Tai H., Kubota N., Kato S. Involvement of nuclear receptor coactivator SRC-1 in estrogen-dependent cell growth of MCF-7 cells. Biochemical and Biophysical Research Communications 2000, 267:311-316.
63. Welshons W.V., Thayer K.A., Judy B.M., Taylor J.A., Curran E.M., vom Saal F.S. Large effects from small exposures. I. Mechanisms for endocrine-disrupting chemicals with estrogenic activity. Environmental Health Perspectives 2003, 111:994-1006.
64. vom Saal F.S., Welshons W.V. Large effects from small exposures. II. The importance of positive controls in low-dose research on bisphenol A. Environmental Research 2006, 100:50-76.
65. vom Saal F.S., Timms B.G., Montano M.M., Palanza P., Thayer K.A., Nagel S.C., et al. Prostate enlargement in mice due to fetal exposure to low doses of estradiol or diethylstilbestrol and opposite effects at high doses. Proceedings of the National Academy of Sciences of the United States of America 1997, 94:2056-2061.
66. Gupta C. Reproductive malformation of the male offspring following maternal exposure to estrogenic chemicals. Proceedings of the Society for Experimental Biology and Medicine 2000, 224:61-68.
67. Honma S., Suzuki A., Buchanan D.L., Katsu Y., Watanabe H., Iguchi T. Low dose effect of in utero exposure to bisphenol A and diethylstilbestrol on female mouse reproduction. Reproductive Toxicology 2002, 16:117-122.
68. Timms B.G., Howdeshell K.L., Barton L., Bradley S., Richter C.A., vom Saal F.S. Estrogenic chemicals in plastic and oral contraceptives disrupt development of the fetal mouse prostate and urethra. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:7014-7019.
69. Klein S., Allison D.B., Heymsfield S.B., Kelley D.E., Leibel R.L., Nonas C., et al. Waist circumference and cardiometabolic risk: a consensus statement from Shaping America's Health: Association for Weight Management and Obesity Prevention; NAASO, the Obesity Society; the American Society for Nutrition; and the American Diabetes Association. Obesity (Silver Spring) 2007, 15:1061-1067.
70. Thayer K.A., Heindel J.J., Bucher J.R., Gallo M.A. Role of environmental chemicals in diabetes and obesity: a National Toxicology Program workshop review. Environmental Health Perspectives 2012, 120:779-789.
71. Tyl R.W., Myers C., Marr M., Sloan C.S., Castillo N., Veselica M.M., et al. Two-generation reproductive toxicity study of dietary bisphenol A (BPA) in CD-1® (Swiss) mice. Toxicological Sciences 2008, 102:362-384.
72. Blumberg B. Obesogens, stem cells and the maternal programming of obesity. Journal of Developmental Origins of Health and Disease 2011, 2:3-8.
73. Li X., Ycaza J., Blumberg B. The environmental obesogen tributyltin chloride acts via peroxisome proliferator activated receptor gamma to induce adipogenesis in murine 3T3-L1 preadipocytes. Journal of Steroid Biochemistry and Molecular Biology 2011, 127:9-15.
74. Li X., Pham H.T., Janesick A.S., Blumberg B. Triflumizole is an obesogen in mice that acts through peroxisome proliferator activated receptor gamma (PPARgamma). Environmental Health Perspectives 2012, 120:1720-1726.
75. Chamorro-Garcia R., Kirchner S., Li X., Janesick A., Casey S.C., Chow C., et al. Bisphenol A diglycidyl ether induces adipogenic differentiation of multipotent stromal stem cells through a peroxisome proliferator-activated receptor gamma-independent mechanism. Environmental Health Perspectives 2012, 120:984-989.
76. Karastergiou K., Mohamed-Ali V. The autocrine and paracrine roles of adipokines. Molecular and Cellular Endocrinology 2010, 318:69-78.
77. Wasim H., Al-Daghri N.M., Chetty R., McTernan P.G., Barnett A.H., Kumar S. Relationship of serum adiponectin and resistin to glucose intolerance and fat topography in South-Asians. Cardiovascular Diabetology 2006, 5:10.
78. Kadowaki T., Yamauchi T. Adiponectin and adiponectin receptors. Endocrine Reviews 2005, 26:439-451.
79. Alonso-Magdalena P., Morimoto S., Ripoll C., Fuentes E., Nadal A. The estrogenic effect of bisphenol A disrupts pancreatic beta-cell function in vivo and induces insulin resistance. Environmental Health Perspectives 2006, 114:106-112.
80. Barros R.P., Morani A., Moriscot A., Machado U.F. Insulin resistance of pregnancy involves estrogen-induced repression of muscle GLUT4. Molecular and Cellular Endocrinology 2008, 295:24-31.
81. Foryst-Ludwig A., Kintscher U. Metabolic impact of estrogen signalling through ERalpha and ERbeta. Journal of Steroid Biochemistry and Molecular Biology 2010, 122:74-81.
82. Soriano S., Alonso-Magdalena P., Garcia-Arevalo M., Novials A., Muhammed S.J., Salehi A., et al. Rapid insulinotropic action of low doses of bisphenol-A on mouse and human islets of Langerhans: role of estrogen receptor beta. PLoS ONE 2012, 7:e31109.
83. Cao J., Mickens J.A., McCaffrey K.A., Leyrer S.M., Patisaul H.B. Neonatal bisphenol A exposure alters sexually dimorphic gene expression in the postnatal rat hypothalamus. Neurotoxicology 2012, 33:23-36.
84. Broberger C. Brain regulation of food intake and appetite: molecules and networks. Journal of Internal Medicine 2005, 258:301-327.
85. Inui A. Transgenic study of energy homeostasis equation: implications and confounding influences. FASEB Journal 2000, 14:2158-2170.
86. Eva C., Serra M., Mele P., Panzica G., Oberto A. Physiology and gene regulation of the brain NPY Y1 receptor. Frontiers in Neuroendocrinology 2006, 27:308-339.
87. Bertocchi I., Oberto A., Longo A., Mele P., Sabetta M., Bartolomucci A., et al. Regulatory functions of limbic Y1 receptors in body weight and anxiety uncovered by conditional knockout and maternal care. Proceedings of the National Academy of Sciences of the United States of America 2012, 108:19395-19400.
88. Ding B., Kull B., Liu Z., Mottagui-Tabar S., Thonberg H., Gu H.F., et al. Human neuropeptide Y signal peptide gain-of-function polymorphism is associated with increased body mass index: possible mode of function. Regulatory Peptides 2005, 127:45-53.
89. Ukkola O., Kesaniemi Y.A. Leu7Pro polymorphism of PreproNPY associated with an increased risk for type II diabetes in middle-aged subjects. European Journal of Clinical Nutrition 2007, 61:1102-1105.
90. Gao Q., Horvath T.L. Cross-talk between estrogen and leptin signaling in the hypothalamus. American Journal of Physiology, Endocrinology and Metabolism 2008, 294:E817-E826.
91. Martini M., Miceli D., Gotti S., Viglietti-Panzica C., Fissore E., Palanza P., et al. Effects of perinatal administration of Bisphenol A on the neuronal nitric oxide synthase expressing system in the hypothalamus and limbic system of CD1 mice. Journal of Neuroendocrinology 2010, 22:1004-1012.
92. Vianna C.R., Coppari R. A treasure trove of hypothalamic neurocircuitries governing body weight homeostasis. Endocrinology 2011, 152:11-18.
93. Morrissey R.E., George J.D., Price C.J., Tyl R.W., Marr M.C., Kimmel C.A. The developmental toxicity of bisphenol A in rats and mice. Fundamental and Applied Toxicology 1987, 8:571-582.
94. IRIS Bisphenol A (CASRN 80-05-7); US-EPA Integrated Risk Information System Substance File 1988.
95. vom Saal F.S., Sheehan D.M. Challenging risk assessment. Forum for Applied Research and Public Policy 1998, 13:11-18.
96. Myers J.P., Zoeller R.T., vom Saal F.S. A clash of old and new scientific concepts in toxicity, with important implications for public health. Environmental Health Perspectives 2009, 117:1652-1655.